Marcela Maus, MD, PhD

Dr. Marcela Maus is currently an Associate Professor at Harvard Medical School, the Paula O’Keefe Chair in Oncology and Director of Cellular Immunotherapy at Massachusetts General Hospital (MGH) Cancer Center, an Attending Physician in the Hematopoietic Cell Transplant and Cell Therapy division of Oncology at MGH. She is an Associate Member of the Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), and an Associate Member of the Ragon Institute of MGH, MIT and Harvard.

Maus is internationally known for her work as a translational physician-scientist in the field of immunology, particularly as it relates to T-cell immunotherapies and cellular therapies in the treatment of cancer.
Her laboratory focuses on the biology of human T-cell activation, costimulation and memory, and on the application of human T-cell therapies to human disease, including forward and reverse translation of engineered T-cell therapies in early-phase clinical trials.

Maus has authored more than 100 papers indexed in PubMed and holds multiple NIH R01 grants and several Investigational New Drug Applications. She completed undergraduate studies at MIT and holds graduate degrees (MD, PhD) from University of Pennsylvania.

Maus trained in internal medicine at University of Pennsylvania and in hematology and medical oncology at Memorial Sloan Kettering Cancer Center, is board-certified in these three disciplines and practices medical oncology.

She also serves on several scientific and clinical advisory boards for the biotechnology industry as well as external academic medical centers.